Gut microbe-derived metabolites and the risk of cardiovascular disease in the METSIM cohort

By sjmartinez • August 17, 2024

Mirzaei S, DeVon HA, Cantor RM, Cupido A, Fernandes Silva L, Laakso M, Lusis AJ. Gut microbe-derived metabolites and the risk of cardiovascular disease in the METSIM cohort. Front Microbiol. 2024 Aug 1;15:1411328. doi: 10.3389/fmicb.2024.1411328. PMID: 39149211; PMCID: PMC11324590.

Tags: Cardiology/Epi, cardiovascular disease, gut metabolites, myocardial infarction, Post Doc, Publications, stroke, succinate, ursodeoxycholic acid

GLP-1 Receptor Agonist in Non-obese Patients with Type-2 Diabetes Mellitus and Heart Failure with Preserved Ejection Fraction

Khadke S, Kumar A, Bhatti A, Dani SS, Al-Kindi S, Nasir K, Virani SS, Upadhyay J, Garcia-Banigan DC, Abraham S, Husami R, Kong Y, Labib[...]

Resolution of ventricular tachycardia and cardiac inflammation following treatment in chronic Chagas disease

Malik A, Jiang M, Muñoz G, Meymandi S, Bradfield JS, Hayase J. Resolution of ventricular tachycardia and cardiac inflammation following treatment in chronic Chagas disease.[...]

Transcatheter Edge-to-Edge Repair in Patients With Complex Tricuspid Valve Anatomy

Adams DH, Tang GHL, Whisenant BK, Kodali SK, Singh GD, Fam NP, Kar S, Price MJ, Spies C, Schwartz JG, Makkar RR, Tadros P, Asgar[...]